Thought Leadership

THOUGHT LEADERSHIP

Our commitment to advancing the field is demonstrated through peer-reviewed research and international conference presentations. Below is a selection of our team’s contributions.

1. Mahon R, Choudhury SP, Dutta SK, Majumdar AD, Ghosh B, Demla C, Thomas A, Dey D. (2026)

Recommendations for the Use of Early Cost-Effectiveness Analysis to Inform the Health Technology Development Process with an Application to Cutaneous Squamous Cell Carcinoma. International Journal of Technology Assessment in Health Care, 42(1), e7.

2. Bisen R, Thakur L, Puthran D. (2025)

Evaluating Therapeutic Landscape in Radio-Iodine-Refractory Differentiated Thyroid Cancer (DTC): A Bayesian Network Meta-Analysis of Clinical Efficacy. Value in Health, 28(12 Suppl 1), S64.

3. Bisen R, Thakur L, Puthran D. (2025)

The Impact of Network Meta-Analyses on HTA Decisions in Oncology: A Review of NICE Appraisals. Value in Health, 28(12 Suppl 1), S92.

4. Thakur L, Bisen R, Puthran D. (2025)

Budget Impact Analysis of GLP-1 Receptor Agonists for Type 2 Diabetes Management in India. Value in Health, 28(12 Suppl 1), S116-S117.

5. Sharma A, Thakur L, Bisen R. (2025)

Budget Analysis of Lenvatinib and Sorafenib as First-Line Treatments for Radioiodine-Refractory Differentiated Thyroid Cancer in the United States. Value in Health, 28(6 Suppl 1), S72.

6. Dey D, Harper J, Paul CS, Dutta S, Thomas A, Bhattacharyya S, Padula W, Lin T, Olujohungbe O, Jospeh G, Dashputre A. (2024)

A Cost-Effectiveness Analysis of a Triple-Agent Topical Fixed-Dose Combination of 1.2% Clindamycin Phosphate, 0.15% Adapalene, and 3.1% Benzoyl Peroxide Gel for the Treatment of Moderate-to-Severe Acne Vulgaris in the United States. Value in Health, 27(6 Suppl), S131.

7. Thomas A, Harper J, Soni P, Dey D, Bhattacharyya S, Cohen B, Lin T, Olujohungbe O, Samson A, Bumpass B, Jospeh G, Dashputre A. (2024)

Budget Impact Analysis of a Triple-Agent Fixed-Dose Combination of 1.2% Clindamycin Phosphate, 0.15% Adapalene, and 3.1% Benzoyl Peroxide Topical Gel for the Treatment of Patients With Moderate-to-Severe Acne Vulgaris in the US. Value in Health, 27(6 Suppl), S59.

8. Sil A, Dutta MA, Choudhury P, Chatterjee K, Dutta S. (2024)

Navigating the Clinical Effectiveness Challenges for Orphan Drug Assessments: A NCPE Review. Value in Health, 27(6 Suppl), S258-S259.

9. Choudhury SP, Majumdar AD, Sil A, Dutta S, Mahon R. (2024)

A Comparative Analysis of Missing Value Imputation Techniques: Spline vs Markov Chain Monte Carlo & Machine Learning Algorithms. Value in Health, 27(12 Suppl), S472.

10. Choudhury P, Sil A, Chatterjee K, Dutta S. (2024)

Addressing the Overlooked Inquiry in Feasibility Assessment of Network Meta-Analysis through the Covariate-Optimized Spatial Method for Integrated Clustering (COSMIC). Value in Health, 27(6 Suppl), S270.

11. Chatterjee K, Paul CS, Dutta MA, Sil A, Dutta S. (2024)

Evaluating the Evolution of Patient-Reported Outcome Measures (PROMs) in Health Technology Assessments: A Focus on Neurological Diseases in NICE Technology Appraisals. Value in Health, 27(6 Suppl), S303.

12. Bisen R, Thakur L, Shivsingwale G. (2024)

Evaluating Therapeutics Landscape in Differentiated Thyroid Cancer (DTC): A Systematic Review of Clinical Efficacy and Safety. Systematic Literature Review and Meta-Analysis, 5(2). Published 10 July 2024, 2024.

13. Bisen R, Thakur L, Shivsingwale G, Gunde D, Mukta Y. (2024)

A Systematic Review of Pharmacological Interventions for Hidradenitis Suppurativa: A Focus on Clinical Response, Quality of Life, and Safety. ISPOR Europe, 17-20 November 2024, Barcelona, Spain.

14. Bisen R, Thakur L, Shivsingwale G, Gunde D, Mukta Y. (2024)

Insight from Randomized Controlled Trials on the Efficacy and Safety of Pharmacological Therapies for Differentiated Thyroid Cancer: A Systematic Review. ISPOR Europe, 17-20 November 2024, Barcelona, Spain.

15. Harper JC, Baldwin HE, Choudhury SP, Ghosh B, Rai D, Aman MS, Choudhury AR, Dey D, Dutta SK, Bhattacharyya S, Lin T. (2023)

A Systematic Literature Review and Network Meta-Analysis of Comparative Efficacy of Topical Fixed-Dose Combination Treatments for Moderate to Severe Acne Vulgaris. SKIN: The Journal of Cutaneous Medicine, 7(6), s290-s290.

16. Choudhury SP, Majumdar AD, Sil A, Dutta S. (2023)

A Comparative Analysis of Missing Value Imputation Techniques: Parametric Imputation with eCDF (PIE) vs Markov Chain Monte Carlo Imputation (MCMC). Value in Health, 26(12 Suppl), S398-S399.

17. Bisen R, Thakur L, Bisen V, Shivsingwale G. (2023)

Burden of Chronic Lymphocytic Leukemia in the United States: A Review of Literature. ISPOR Europe, 12-15 November 2023, Copenhagen, Denmark.

18. Bisen R, Thakur L, Shivsingwale G, Mukta Y, Gunde D. (2023)

Economic Evaluations of Pharmacological Interventions for Lupus Population - A Targeted Literature Review. ISPOR Europe, 12-15 November 2023, Copenhagen, Denmark.

19. Bisen R, Thakur L, Shivsingwale G, Gunde D, Mukta Y. (2023)

A Targeted Literature Review of Cost-Utility Analyses for Ulcerative Colitis/Crohn's Disease Treatment. ISPOR Europe, 12-15 November 2023, Copenhagen, Denmark.

20. Proudfoot C, Gautam R, Cristino J, Agrawal R, Thakur L, Tolley K. (2023)

Model Parameters Influencing the Cost-Effectiveness of Sacubitril/Valsartan in Heart Failure: Evidence from a Systematic Literature Review. The European Journal of Health Economics, 24(3), 453-467.

21. Shaddy R, George A, Jaecklin T, Nic Lochlainn E, Thakur L, Agrawal R, Solar-Yohay S, Chen F, Rossano J, Severin T, Burch M. (2019)

Systematic Literature Review on the Incidence and Prevalence of Heart Failure in Children and Adolescents. Pediatric Cardiology, 2019.

22. Burch M, Nallagangula T, Nic Lochlainn E, Severin T, Thakur L, Jaecklin T, George A, Solar-Yohay S, Rossano J, Shaddy R. (2019)

Systematic Literature Review on the Economic, Humanistic, and Societal Burden of Heart Failure in Children and Adolescents. Expert Review of Pharmacoeconomics & Outcomes Research, 2019.

23. Kuemmerle-Deschner J, Thakur L, George A, Hur P. (2019)

A Systematic Review of the Effectiveness and Safety of Pharmacological Treatments in Systemic Idiopathic Juvenile Arthritis (SJIA). EULAR Congress, Madrid, 2019.

24. Kaushik N, Bisen R, Bhutani MK, Taneja A. (2018)

Economic Burden of Fragile X Syndrome in Europe and the US: A Systematic Literature Review. ISPOR Europe, 10-14 November 2018, Barcelona, Spain.

25. Sharma N, Bisen R, Rawat NS, Afaque A, Gupta S. (2018)

Economic Burden of Myasthenia Gravis in the US: A Literature Review. ISPOR US, 19-23 May 2018, Baltimore, MD, USA.

26. Ahuja A, Agrawal R, Thakur L, Natani H, Cristino J, Croft D, Gielen V. (2017)

Randomized Controlled Trials in Heart Failure with Preserved Ejection Fraction (HFpEF): A Systematic Review of Patient Populations. ISPOR Europe, 5-9 November 2017, Glasgow, Scotland.

27. Agrawal R, Ahuja A, Thakur L, Natani H, Cristino J, Croft D, Gielen V. (2017)

A Systematic Review on the Efficacy of Pharmacological Treatments in Heart Failure with Preserved Ejection Fraction (HFpEF). ISPOR Europe, 5-9 November 2017, Glasgow, Scotland.

28. Srivastava K, Rajora P, Gupta S, Bisen R. (2015)

Evidence Review Group Critique of Systematic Reviews Submitted to NICE as Part of Single Technology Appraisals (STA) or Multiple Technology Appraisals (MTA) in the Last Three Years. ISPOR Europe, 7-11 November 2015, Milan, Italy.